(Q45992756)

English

Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study.

scientific article published on 21 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24255954

Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24255954

positron emission tomography

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Calogero Saieva

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

10

object named as

Beatrice Detti

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Tommaso Cai

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Giampaolo Siena

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Andrea Minervini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Mozhgan Fayaz Torshizi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Matteo Bartolini

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Gianluca Giannì

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Mauro Ceroti

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Lorenzo Livi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Marco Carini

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

21 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24255954

Scandinavian journal of urology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

259-267

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Management of asymptomatic rise in prostatic-specific antigen in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Clinical Indications of C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Visualization of prostate cancer with 11C-choline positron emission tomography

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: treating to doses beyond 78 Gy.

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Analysis of clustered data in receiver operating characteristic studies

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Management of biochemical recurrence after primary localized therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Clinical Application of High-Dose, Image-Guided Intensity-Modulated Radiotherapy in High-Risk Prostate Cancer

1 reference

https://api.crossref.org/works/10.3109%2F21681805.2013.846936

21 January 2018

Identifiers

10.3109/21681805.2013.846936

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24255954%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45992756&oldid=1743714134"